In osteosarcoma, tumor antagonizing immune cells, particularly activated CD4+ T cells, activated CD8+ T cells, central memory CD4+ and CD8+ T cells, M1 macrophages, natural killer (NK) cells, and tumor-associated neutrophils (TANs) are detected at relatively lower levels in patients with shorter survival rates (13–17). This evidence concerns the gene CD8A and neoplasm.